Streamline Other Non Cash Items from 2010 to 2024

STRM Stock  USD 2.78  0.26  8.55%   
Streamline Health Other Non Cash Items yearly trend continues to be very stable with very little volatility. Other Non Cash Items is likely to grow to about 9.3 M this year. During the period from 2010 to 2024, Streamline Health Other Non Cash Items quarterly data regression pattern had sample variance of 14.5 T and median of  544,000. View All Fundamentals
 
Other Non Cash Items  
First Reported
1996-07-31
Previous Quarter
3.1 M
Current Value
207 K
Quarterly Volatility
1.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Streamline Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Streamline Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 M, Total Revenue of 19.1 M or Gross Profit of 9.9 M, as well as many indicators such as Price To Sales Ratio of 0.93, Dividend Yield of 0.0 or PTB Ratio of 1.11. Streamline financial statements analysis is a perfect complement when working with Streamline Health Valuation or Volatility modules.
  
Check out the analysis of Streamline Health Correlation against competitors.

Latest Streamline Health's Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of Streamline Health Solutions over the last few years. It is Streamline Health's Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Streamline Health's overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Pretty Stable
   Other Non Cash Items   
       Timeline  

Streamline Other Non Cash Items Regression Statistics

Arithmetic Mean2,006,963
Geometric Mean1,052,856
Coefficient Of Variation189.52
Mean Deviation3,138,636
Median544,000
Standard Deviation3,803,510
Sample Variance14.5T
Range12.5M
R-Value0.25
Mean Square Error14.6T
R-Squared0.06
Significance0.38
Slope209,480
Total Sum of Squares202.5T

Streamline Other Non Cash Items History

20249.3 M
20238.8 M
2022118 K
2021-3.2 M
2020-1.8 M
2019544 K
20185.3 M

About Streamline Health Financial Statements

Streamline Health investors utilize fundamental indicators, such as Other Non Cash Items, to predict how Streamline Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Non Cash Items8.8 M9.3 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:
Check out the analysis of Streamline Health Correlation against competitors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
12.131
Earnings Share
(4.80)
Revenue Per Share
5.249
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.11)
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.